In a study that aimed to predict the outcome in Korean women who underwent surgery for breast carcinoma, the E2F1-positive group had less tumor recurrences, lymph node metastasis during follow-up, and distant metastasis than the E2F1-negative group [19]. Here, E2F1 is linked to breast carcinoma.